Code | 64989 | ||||||||||
MA number | EU/1/08/492/003 | ||||||||||
Product Form: | con inf 1x10 ml/200 mg (liek.inj.skl.) | ||||||||||
MA Status: | E - Valid centralised marketing authorisation | ||||||||||
Type of procedure: | EU | ||||||||||
MAH, country: | Roche Registration GmbH, Germany | ||||||||||
Therapeutic Class: | 59 - IMMUNOPRAEPARATA | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 30 | ||||||||||
Container: | glass vial | ||||||||||
Route of admin.: | Intravenous use |
Prescription Status: | Medicinal product subject to restricted medical prescription. |
Legal basis: | Article 8(3) application |
MA issued: | 16.01.2009 |
SmPC + PL: | European Medicines Agency's database |
Dokument: | tocilizumab_prirucka pre pacienta.pdf |
Dokument: | tocilizumab_prirucka k podavaniu lieku.pdf |
Dokument: | tocilizumab_prirucka pre zdravotnickych pracovnikov.pdf |
Dokument: | tocilizumab_karta pacienta.pdf |
Safety feature | Yes |
Data update: | 01.02.2023 |